EPT Fumarate: A Novel Therapeutic Agent for Mitochondrial Dysfunction
Mitochondrial dysfunction plays a wide range of degenerative diseases. This impairment in mitochondrial function can lead to cellular failure, ultimately resulting in diverse pathologies. EPT Fumarate, a novel therapeutic agent, has emerged as a promising treatment for addressing this debilitating issue. EPT Fumarate operates by enhancing the acti